The substernal extravascular implantable cardioverter-defibrillator showed successful defibrillation, pacing, and sensing with no acute major complications in most patients.
Is the chronic implantation of a substernal extravascular implantable cardioverter-defibrillator feasible and safe?
Patients undergoing first-in-human evaluation of an extravascular implantable cardioverter-defibrillator (EV ICD)
Substernal extravascular implantable cardioverter-defibrillator (EV ICD)
Feasibility of substernal lead placement, defibrillation, and pacing, and acute major complicationssafety
First-in-human evaluation demonstrates that a substernal extravascular ICD is feasible and acutely safe for pacing and defibrillation.
Absolute Event Rate: 0% vs 0%
This first-in-human evaluation of an EV ICD demonstrated the feasibility of substernal lead placement, defibrillation, and pacing with a chronically implanted system. There were no acute major complications, and pacing, defibrillation, and sensing performance at implantation were successful in most patients. (Extravascular ICD Pilot Study EV ICD; NCT03608670).
Building similarity graph...
Analyzing shared references across papers
Loading...
Ian Crozier
Electrophysiology
Haris M. Haqqani
Electrophysiology
Emily Kotschet
Electrophysiology
JACC. Clinical electrophysiology
Monash Medical Centre
Austin Hospital
Christchurch Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Crozier et al. (Wed,) reported a other. The substernal extravascular implantable cardioverter-defibrillator showed successful defibrillation, pacing, and sensing with no acute major complications in most patients.
synapsesocial.com/papers/69714deaf15775e61fbf1e39 — DOI: https://doi.org/10.1016/j.jacep.2020.05.029